LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

VIYASH

NSEBSE
Viyash Scientific Limited
Healthcare· Pharmaceuticals & Biotechnology· INE807F01027· Scrip: 512529
ENहिन्दीગુજરાતીमराठी
207.22
3.05 (-1.45%)
29/4/2026, 3:18:55 pm
NSE
207.22
3.05
-1.45%
BSE
210.05
1.25
+0.00%
18719720721722701-2302-0602-1903-0503-1804-0804-2204-28
59 trading days · 1Y period
TODAY
Open210.12
High212.83
Low207.00
Prev Close210.27
Volume4.33L
Value₹9.1Cr
L: 207.00H: 212.83
52 WEEK
Low141.63
High257.85
56% of 52W range
Info
Face Value₹2
Listed2016-03-10
ISININE807F01027
SeriesB
BSE Scrip512529

Key Metrics

1D
-0.77%
1W
-0.40%
1M
+9.23%
3M
6M
Valuation
P/E (TTM)545.32
Mkt Cap₹8344 Cr
Growth (QoQ)
Revenue+6.01%
PAT+2.21%
EPS+40.00%
Dividend
Yield0.24%
Growth+150.00%
TTM Revenue
₹1178 Cr
TTM EBITDA
₹77 Cr
TTM PAT
₹19 Cr
TTM EPS
₹0.38
Rev/Share
₹27.0

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr98 Cr195 Cr293 Cr391 Cr22-1223-0323-0923-1224-0324-0624-0924-12-0.4-3.8-0.30.3-0.00.20.10.1
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31391 Cr388 Cr25 Cr8 Cr6 Cr0.14
2024-09-30369 Cr361 Cr25 Cr8 Cr6 Cr0.10
2024-06-3058 Cr62 Cr8 Cr6 Cr5 Cr0.18
2024-03-31361 Cr358 Cr19 Cr3 Cr1 Cr-0.04
2023-12-31329 Cr335 Cr17 Cr1 Cr11 Cr0.33
2023-09-30346 Cr359 Cr12 Cr-3 Cr-7 Cr-0.34
2023-03-31367 Cr396 Cr-74 Cr-89 Cr-92 Cr-3.77
2022-12-31375 Cr388 Cr3 Cr-10 Cr-10 Cr-0.36

Shareholding Pattern

CURRENT2026-03-31
61.3%PROMOTER
Promoter61.3%
FII2.9%
DII8.0%
Public38.6%
PROMOTER HOLDING TREND
52.8%24-0952.6%24-1252.6%25-0352.3%25-0961.4%25-1261.4%25-1261.3%26-03

Corporate Actions

Ex-DateTypePurpose
2021-09-08Dividend Dividend - Rs 0.50 Per Share
2019-08-21Dividend Annual General Meeting/Dividend - Rs 0.20 Per Share
2018-04-06Other Scheme Of Arrangement
2017-11-20Dividend Interim Dividend - Re 0.20 Per Share
2016-09-15Other Annual General Meeting

Earnings Transcripts

Sequent Scientific Limited has informed the Exchange about Investor Presentation
18 Nov 2025NSE15K chars
Read →
Sequent Scientific Limited has informed the Exchange about Investor Presentation
17 Nov 2025NSE14K chars
Read →
Sequent Scientific Limited has informed the Exchange about Investor Presentation
14 Nov 2025NSE14K chars
Read →
Sequent Scientific Limited has informed the Exchange about Investor Presentation
20 May 2025NSE27K chars
Read →
Sequent Scientific Limited has informed the Exchange about Investor Presentation
11 Feb 2025NSE20K chars
Read →
Sequent Scientific Limited has informed the Exchange about Investor Presentation
15 Feb 2024NSE11K chars
Read →
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Dis...
5 Aug 2023NSE1K chars
Read →
Sequent Scientific Limited has informed the Exchange about Investor Presentation
23 May 2023NSE12K chars
Read →
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and ...
21 Feb 2023NSE48K chars
Read →
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and ...
15 Feb 2023NSE2K chars
Read →
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Dis...
8 Feb 2023NSE2K chars
Read →
Sequent Scientific Limited has informed the Exchange about Transcript of Analysts/Institutional Inve...
14 Nov 2022NSE1K chars
Read →
Sequent Scientific Limited has informed the Exchange that the audio recording of the earnings call m...
8 Nov 2022NSE2K chars
Read →
Sequent Scientific Limited has informed the Exchange that Pursuant to Regulation 30 of the Securitie...
3 Nov 2022NSE2K chars
Read →
Sequent Scientific Limited has informed the Exchange about Transcript of Analysts/Institutional Inve...
16 Aug 2022NSE46K chars
Read →
In continuation with our letter dated August 01, 2022, please note the URL for prior (early) registr...
8 Aug 2022NSE2K chars
Read →
Sequent Scientific Limited has informed the Exchange about Schedule of Analysts/Institutional Invest...
1 Aug 2022NSE2K chars
Read →
Sequent Scientific Limited has informed the Exchange about Transcript of Analysts/Institutional Inve...
30 May 2022NSE45K chars
Read →
Sequent Scientific Limited has informed the Exchange regarding a revised press release dated Februar...
3 Feb 2021NSE15K chars
Read →
Sequent Scientific Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/...
21 Jan 2020NSE2K chars
Read →

Price History

DateOpenHighLowCloseVolume
2026-04-28209.95212.00208.30210.274.83L
2026-04-27207.95210.00207.10208.825.73L
2026-04-24212.00212.00205.06207.156.22L
2026-04-23209.61216.48209.61211.7610.53L
2026-04-22207.00212.28207.00209.616.40L
2026-04-21207.35213.18207.35208.056.81L
2026-04-20208.00210.29206.05207.315.76L
2026-04-17207.00210.98206.05208.2510.77L
2026-04-16212.90212.90205.53208.248.42L
2026-04-15207.86214.78207.85210.208.81L
2026-04-13202.55208.34201.90205.255.78L
2026-04-10205.65209.81205.23208.757.82L
2026-04-09209.00212.47203.01204.9614.09L
2026-04-08200.20210.90198.58206.8710.58L
2026-04-07195.50201.49192.76194.367.20L
2026-04-02188.98192.38186.00191.763.69L
2026-04-01186.99195.31186.99192.935.65L
2026-03-27192.00194.40186.00187.506.83L
2026-03-25190.00195.20190.00193.727.37L
2026-03-24185.40192.50185.00188.789.65L
2026-03-20190.01194.76188.00188.435.46L
2026-03-19192.00194.69189.00189.715.92L
2026-03-18191.15199.40191.15195.327.97L
2026-03-17195.10195.78190.50192.507.45L
2026-03-16196.65198.73190.90194.678.26L
2026-03-13196.06199.30190.71197.309.69L
2026-03-12194.74199.10191.45196.066.95L
2026-03-11199.00200.82195.00195.325.00L
2026-03-10192.73198.51189.62197.4511.62L
2026-03-09195.88197.00190.17190.677.58L

Frequently Asked Questions

About

Sequent Scientific Limited, formerly known as Viyash Scientific Limited, is an Indian company incorporated in 1985 and listed on the NSE and BSE. It operates as a leading player in the global animal health sector, specializing in the manufacturing and distribution of veterinary vaccines, particularly for the poultry industry. The company has a significant market presence, with a consolidated turnover of ₹13.69 billion and a market capitalization of approximately ₹29.33 billion, and has expanded its operations through subsidiaries and strategic acquisitions.

BOARD OF DIRECTORS
Manish Gupta
Managing Director
DEPARTED
Kausalya Santhanam
Independent Director
DEPARTED
Narendra Mairpady
Independent Director
Rahul Mukim
Independent Director
DEPARTED
Gregory John Andrews
Additional Director
Hari Babu Bodepudi
Additional Director